Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Humacyte revenue
Humacyte's revenue is $1.6 million.
What is Humacyte's revenue?
- Humacyte's revenue growth from 2020 to 2022 is 4.96%.
- Humacyte has 130 employees, and the revenue per employee ratio is $12,038.
- Humacyte peak revenue was $1.6M in 2022.
- Humacyte annual revenue for 2021 was 1.3M, -15.29% growth from 2020.
- Humacyte annual revenue for 2022 was 1.6M, 23.91% growth from 2021.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Humacyte historical revenue
Humacyte annual revenue
Humacyte annual revenue over time
| Fiscal year / year | Humacyte revenue |
|---|---|
| 2020 | $1.5M |
| 2021 | $1.3M |
| 2022 | $1.6M |
Humacyte jobs nearby
Do you work at Humacyte?
Did Humacyte meet its revenue projections?
Humacyte financing
Humacyte received early financing of $7.0M on 2009-11-01.
| Series | Round size | Date |
|---|---|---|
| Debt Financing | $7M | 11/2009 |
| Debt Financing | $12M | 09/2010 |
| Debt Financing | $49.8M | 01/2015 |
| Series B | $150M | 10/2015 |
| Series Unknown | $10M | 08/2016 |
| Grant | $14.1M | 09/2017 |
| Series C | $75.0M | 03/2018 |
| Corporate Round | $150M | 06/2018 |
| Debt Financing | $50M | 04/2021 |
| Post Ipo Equity | $175M | 08/2021 |
Humacyte investors
| Investors | Security type |
|---|---|
| Carrie Cox | Debt Financing |
| Access Industries | Series B |
| Bangkok Bank | Series B |
| Pacific Eagle Holdings | Series B |
| Reignwood Group | Series B |
| Gavril Yushvaev | Series B |
| Brady Dougan | Series B |
| California Institute for Regenerative Medicine | Series Unknown |
| California Institute for Regenerative Medicine | Grant |
| FRESENIUS MEDICAL CARE AG & CO. KGAA | Corporate Round |
| SVB Financial Group | Debt Financing |
| Morgan Creek Capital Management LLC | Post Ipo Equity |
| UBS O'Connor | Post Ipo Equity |
| Monashee Investment Management LLC | Post Ipo Equity |
| OrbiMed Advisors | Post Ipo Equity |
| FRESENIUS MEDICAL CARE AG & CO. KGAA | Post Ipo Equity |
| Alexandria Venture Investments | Post Ipo Equity |
Humacyte competitors
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| GetWellNetwork, Inc. | $76,301 | $11.0M | 220 | 5 |
| Advanced Home Care | $42,190 | $210.0M | 3,000 | 3 |
| Blueprint Medicines | $84,447 | $508.8M | 495 | 6 |
| Infinity Pharmaceuticals | $66,608 | $2.6M | 100 | - |
| Vericel Corp | $48,460 | $45.9M | 216 | 25 |
| Scantibodies Laboratory | $52,404 | $290.0M | 620 | - |
| BioLife Solutions | $46,964 | $119.2M | 54 | 709 |
| Immucor | $60,486 | $380.0M | 1,125 | - |
| Biomérieux | $62,385 | - | 6,828 | 93 |
| Lifecore | $51,986 | $150.0M | 255 | 7 |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Humacyte highest paying jobs
Zippia gives an in-depth look into the details of Humacyte, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Humacyte. The employee data is based on information from people who have self-reported their past or current employments at Humacyte. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Humacyte. The data presented on this page does not represent the view of Humacyte and its employees or that of Zippia.
Humacyte may also be known as or be related to HUMACYTE, INC., Humacyte, Humacyte Inc., Humacyte, Inc and Humacyte, Inc.